Tag #Cardiovascular Risk

Showing 1 to 2 of 2 results

elmundo.es
🌐 85% Global Worthiness
News related image

Oral Medication Shows Significant Weight Loss in Obesity Treatment

A phase 3 clinical trial involving 3,100 obese individuals across nine countries demonstrated that orforglipron, a novel oral medication targeting the GLP-1 receptor, resulted in an average 11.2% weight loss, primarily fat mass, and improved cardiovascular risk factors.

Progress

44% Bias Score

Good Health and Well-being
dailymail.co.uk
🌐 85% Global Worthiness
News related image

Pregabalin Linked to Increased Heart Failure Risk

A new study revealed a significantly increased risk of heart failure among pregabalin users, prompting doctors to reassess its prescription, especially in older patients with pre-existing heart conditions.

Progress

36% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results